In this project, we will be investigating a potential therapeutic target for acute myeloid leukemia (AML), which is a type of blood cancer and the five year survival rate is less than 30%. We will be studying a receptor called OR2AT4, which has been found in the white blood cells of AML patients. This receptor […]
Read More